Variant report
Variant | nsv981194 |
---|---|
Chromosome Location | chr6:150276068-150281801 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:27)
- CpG islands (count:122)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:27 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr6:150280757-150280957 | GM12878 | blood: | n/a | chr6:150280887-150280898 chr6:150280888-150280898 |
2 | BHLHE40 | chr6:150280710-150280916 | GM12878 | blood: | n/a | chr6:150280798-150280807 |
3 | CTCF | chr6:150281079-150281326 | K562 | blood: | n/a | n/a |
4 | CTCF | chr6:150281122-150281285 | K562 | blood: | n/a | n/a |
5 | CTCF | chr6:150281183-150281280 | GM20000 | blood: | n/a | n/a |
6 | CUX1 | chr6:150280800-150280909 | GM12878 | blood: | n/a | n/a |
7 | E2F4 | chr6:150281800-150281813 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | E2F6 | chr6:150276225-150276346 | K562 | blood: | n/a | n/a |
9 | FOS | chr6:150279281-150279615 | HUVEC | blood vessel: | n/a | n/a |
10 | FOS | chr6:150280884-150280920 | MCF10A-Er-Src | breast: | n/a | chr6:150280891-150280900 chr6:150280890-150280899 chr6:150280892-150280899 chr6:150280891-150280899 |
11 | FOS | chr6:150280865-150280938 | MCF10A-Er-Src | breast: | n/a | chr6:150280891-150280900 chr6:150280890-150280899 chr6:150280892-150280899 chr6:150280891-150280899 |
12 | FOS | chr6:150280814-150280939 | MCF10A-Er-Src | breast: | n/a | chr6:150280891-150280900 chr6:150280890-150280899 chr6:150280892-150280899 chr6:150280891-150280899 |
13 | GATA1 | chr6:150277206-150277813 | K562 | blood: | n/a | chr6:150277552-150277561 chr6:150277532-150277541 chr6:150277554-150277561 |
14 | GATA2 | chr6:150279321-150279660 | HUVEC | blood vessel: | n/a | chr6:150279450-150279460 |
15 | GATA2 | chr6:150277481-150277669 | SH-SY5Y | brain: | n/a | chr6:150277552-150277561 chr6:150277532-150277541 chr6:150277554-150277561 |
16 | GATA2 | chr6:150277445-150277723 | K562 | blood: | n/a | chr6:150277552-150277561 chr6:150277532-150277541 chr6:150277554-150277561 |
17 | JUND | chr6:150280729-150281014 | HepG2 | liver: | n/a | chr6:150280889-150280900 chr6:150280891-150280900 chr6:150280890-150280899 chr6:150280892-150280899 chr6:150280891-150280899 |
18 | MAX | chr6:150276196-150276365 | K562 | blood: | n/a | chr6:150276261-150276268 chr6:150276260-150276269 |
19 | MYC | chr6:150280197-150280218 | GM12878 | blood: | n/a | n/a |
20 | MYC | chr6:150277502-150277566 | K562 | blood: | n/a | n/a |
21 | POLR2A | chr6:150278334-150278569 | H1-neurons | neurons: | n/a | n/a |
22 | POLR2A | chr6:150281792-150281800 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | POLR2A | chr6:150278310-150278562 | H1-neurons | neurons: | n/a | n/a |
24 | POLR2A | chr6:150277816-150277886 | GM12878 | blood: | n/a | n/a |
25 | RCOR1 | chr6:150277498-150277571 | K562 | blood: | n/a | n/a |
26 | TEAD4 | chr6:150277356-150277693 | K562 | blood: | n/a | n/a |
27 | ZNF263 | chr6:150277151-150277478 | HEK293-T-REx | kidney: | n/a | chr6:150277298-150277307 chr6:150277362-150277371 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:150278437-150278487 | H1-hESC | embryonic stem cell: | embryo |
2 | chr6:150278437-150278487 | NHDF-neo | bronchial: | n/a |
3 | chr6:150278437-150278487 | U87 | brain: | n/a |
4 | chr6:150276311-150276361 | SAEC | small airway: | n/a |
5 | chr6:150278437-150278487 | NH-A | brain: | n/a |
6 | chr6:150276311-150276361 | HAEpiC | amniotic membrane: | n/a |
7 | chr6:150278437-150278487 | BJ | skin: | n/a |
8 | chr6:150278437-150278487 | SKMC | muscle: | n/a |
9 | chr6:150278437-150278487 | HL-60 | blood: | n/a |
10 | chr6:150278437-150278487 | MCF-7 | breast: | n/a |
11 | chr6:150278437-150278487 | GM12892 | blood: | n/a |
12 | chr6:150276311-150276361 | NHBE | bronchial: | n/a |
13 | chr6:150276311-150276361 | Jurkat | blood: | n/a |
14 | chr6:150276311-150276361 | NB4 | blood: | n/a |
15 | chr6:150276311-150276361 | LNCaP | prostate: | n/a |
16 | chr6:150276311-150276361 | HCM | heart: | n/a |
17 | chr6:150278437-150278487 | Hepatocyte | liver: | n/a |
18 | chr6:150278437-150278487 | HPAEpiC | pulmonary alveolar: | n/a |
19 | chr6:150276311-150276361 | HCT-116 | colon: | n/a |
20 | chr6:150276311-150276361 | AG04449 | skin: | fetal |
21 | chr6:150276311-150276361 | Hepatocyte | liver: | n/a |
22 | chr6:150278437-150278487 | ProgFib | skin: | n/a |
23 | chr6:150276311-150276361 | HIPEpiC | eye: | n/a |
24 | chr6:150278437-150278487 | SK-N-SH_RA | brain: | n/a |
25 | chr6:150276311-150276361 | GM12891 | blood: | n/a |
26 | chr6:150276311-150276361 | ovcar-3 | ovarian: | n/a |
27 | chr6:150276311-150276361 | AG09319 | gingival: | n/a |
28 | chr6:150276311-150276361 | HRCEpiC | kidney: | n/a |
29 | chr6:150278437-150278487 | Hela-S3 | cervix: | n/a |
30 | chr6:150278437-150278487 | AG10803 | skin: | n/a |
31 | chr6:150276311-150276361 | HMEC | breast: | n/a |
32 | chr6:150276311-150276361 | AG10803 | skin: | n/a |
33 | chr6:150278437-150278487 | LNCaP | prostate: | n/a |
34 | chr6:150278437-150278487 | AG04450 | lung: | fetal |
35 | chr6:150276311-150276361 | HCF | heart: | n/a |
36 | chr6:150278437-150278487 | IMR90 | lung: | fetal |
37 | chr6:150278437-150278487 | MCF10A-Er-Src | breast: | n/a |
38 | chr6:150278437-150278487 | ovcar-3 | ovarian: | n/a |
39 | chr6:150278437-150278487 | SK-N-SH | brain: | n/a |
40 | chr6:150276311-150276361 | CMK | blood: | n/a |
41 | chr6:150278437-150278487 | A549 | lung: | n/a |
42 | chr6:150276311-150276361 | A549 | lung: | n/a |
43 | chr6:150278437-150278487 | HCM | heart: | n/a |
44 | chr6:150276311-150276361 | Caco-2 | colon: | n/a |
45 | chr6:150278437-150278487 | NB4 | blood: | n/a |
46 | chr6:150276311-150276361 | BJ | skin: | n/a |
47 | chr6:150278437-150278487 | GM12878 | blood: | n/a |
48 | chr6:150278437-150278487 | BE2_C | brain: | n/a |
49 | chr6:150276311-150276361 | BE2_C | brain: | n/a |
50 | chr6:150278437-150278487 | ECC-1 | luminal epithelium: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:150281675..150283348-chr6:150283536..150287148,3 | MCF-7 | breast: | |
2 | chr6:150280454..150282016-chr6:150284184..150286237,2 | K562 | blood: | |
3 | chr6:150276072..150278660-chr6:150282863..150284944,2 | K562 | blood: | |
4 | chr6:149887361..149889007-chr6:150280214..150281779,2 | K562 | blood: | |
5 | chr6:150276089..150279846-chr6:150282631..150286651,4 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ULBP1 | TF binding region |
ULBP1 | CpG island |
ENSG00000055211 | chromatin interactions |
ENSG00000111981 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs377294274 | chr6:150276077-150276078 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575399155 | chr6:150276083-150276084 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543891612 | chr6:150276088-150276089 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563477187 | chr6:150276092-150276093 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs532351718 | chr6:150276094-150276095 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs552167551 | chr6:150276102-150276103 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs559576058 | chr6:150276118-150276119 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs528783086 | chr6:150276157-150276158 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs548645342 | chr6:150276159-150276160 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs9479262 | chr6:150276210-150276211 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs6926109 | chr6:150276233-150276234 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs369125702 | chr6:150276277-150276278 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs397707483 | chr6:150276298-150276299 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs397832412 | chr6:150276304-150276305 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs373537717 | chr6:150276314-150276315 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs550673004 | chr6:150276322-150276323 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs470779 | chr6:150276329-150276330 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs539407220 | chr6:150276340-150276341 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs553015745 | chr6:150276395-150276396 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs372718158 | chr6:150276426-150276427 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs186704401 | chr6:150276493-150276494 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs148393389 | chr6:150276494-150276495 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs555417338 | chr6:150276527-150276528 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs564344488 | chr6:150276575-150276576 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs577778425 | chr6:150276587-150276588 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs544106709 | chr6:150276602-150276603 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs563415712 | chr6:150276605-150276606 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs576931737 | chr6:150276628-150276629 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs540346798 | chr6:150276632-150276633 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs200675604 | chr6:150276650-150276651 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs528513682 | chr6:150276651-150276652 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs371130947 | chr6:150276669-150276670 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs542492552 | chr6:150276721-150276722 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs562272200 | chr6:150276760-150276761 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs531105007 | chr6:150276770-150276771 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs189944276 | chr6:150276772-150276773 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs181745057 | chr6:150276786-150276787 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs570522359 | chr6:150276798-150276799 | Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs186097697 | chr6:150276804-150276805 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs190861751 | chr6:150276827-150276828 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs369326159 | chr6:150276852-150276853 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs566457007 | chr6:150276859-150276860 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs535141696 | chr6:150276937-150276938 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs555615865 | chr6:150276938-150276939 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs76722863 | chr6:150276939-150276940 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs183414256 | chr6:150276983-150276984 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs557531156 | chr6:150277037-150277038 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs147708638 | chr6:150277042-150277043 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs78104861 | chr6:150277051-150277052 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs553084505 | chr6:150277054-150277055 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 17417639 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:150274800-150276200 | Bivalent Enhancer | Primary B cells from peripheral blood | blood |
2 | chr6:150274800-150276200 | Bivalent Enhancer | Primary T helper memory cells from peripheral blood 1 | blood |
3 | chr6:150274800-150276600 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
4 | chr6:150274800-150276600 | Bivalent Enhancer | Primary T helper cells PMA-I stimulated | -- |
5 | chr6:150275000-150276400 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
6 | chr6:150275200-150276400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
7 | chr6:150275600-150276200 | Bivalent/Poised TSS | HepG2 | liver |
8 | chr6:150275600-150276600 | Enhancers | Right Ventricle | heart |
9 | chr6:150275800-150276400 | Bivalent Enhancer | Primary T regulatory cells fromperipheralblood | blood |
10 | chr6:150275800-150276400 | Bivalent Enhancer | Primary T cells effector/memory enriched fromperipheralblood | blood |
11 | chr6:150276200-150276400 | Bivalent Enhancer | Primary T helper 17 cells PMA-I stimulated | -- |
12 | chr6:150276400-150276600 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
13 | chr6:150276400-150276600 | Bivalent Enhancer | Cortex derived primary cultured neurospheres | brain |
14 | chr6:150276400-150276600 | Bivalent Enhancer | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr6:150276400-150276600 | Bivalent Enhancer | Colon Smooth Muscle | Colon |
16 | chr6:150276400-150276600 | Bivalent Enhancer | Stomach Smooth Muscle | stomach |
17 | chr6:150276400-150276800 | Bivalent Enhancer | Primary T helper memory cells from peripheral blood 1 | blood |
18 | chr6:150277000-150277200 | Enhancers | Spleen | Spleen |
19 | chr6:150277200-150277600 | Bivalent Enhancer | K562 | blood |
20 | chr6:150278000-150278200 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr6:150279000-150280200 | Enhancers | HUVEC | blood vessel |
22 | chr6:150280200-150280800 | Bivalent Enhancer | HUVEC | blood vessel |
23 | chr6:150281600-150281800 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
24 | chr6:150281600-150282000 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin03 | Skin |